Skip to Content

Understanding the Shift in Migraine Therapies Over Time

From the early disorganized approach to the now CGRP targeting monocled antibodies, Piero Barbanti, an associate professor of neurology and president of the Italian Headache Sufferers Association, takes us through the eras of treating migraines.

Piero Barbanti

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top